Condition: Chronic Inflammatory Demyelinating Polyneuropathy · CIDP · Chronic Inflammatory Demyelinating Polyradiculoneuropathy · Sponsor: argenx
The main purpose of this study is to demonstrate the efficacy and safety of empasiprubart in adults with CIDP. The study consists of a part A where participants will either receive empasiprubart or placebo for 24 weeks (6 months). Following part A, participants will enter part B in which all participants will receive empasiprubart for 96 weeks (24 months). More information can be found here: https://clinicaltrials.argenx.com/emnergize
This description comes directly from the study's public registry record.
Sabine Coppieters, MD · 857-350-4834 · clinicaltrials@argenx.com
Always discuss trial participation with your own doctor first.
| University of Alabama at Birmingham - 1720 University Blvd | Birmingham, Alabama, United States | Active Not Recruiting |
| Samir Macwan, M.D., Inc. (S corporation) | Rancho Mirage, California, United States | Recruiting |
| Colorado Springs Neurological Associates | Colorado Springs, Colorado, United States | Recruiting |
| Medstar Health Research Institute | Washington D.C., District of Columbia, United States | Recruiting |
| Gables Neurology | Miami, Florida, United States | Recruiting |
| Aqualane Clinical Research | Naples, Florida, United States | Recruiting |
| Paradigm Health System | Slidell, Louisiana, United States | Recruiting |
| Penn Medicine University City | Philadelphia, Pennsylvania, United States | Recruiting |
| National Neuromuscular Research Institute | Austin, Texas, United States | Recruiting |
| NeuroCarePlus | Houston, Texas, United States | Recruiting |
| Instituto Privado Kremer | Córdoba, Argentina | Recruiting |
| Instituto Médico de la Fundación Estudios Clínicos | Rosario, Argentina | Recruiting |
+ 59 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07091630